Lebwohl David 4
4 · Intellia Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Lebwohl David
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-01-01−3,187→ 3,189 totalFrom: 2024-01-01Exp: 2031-03-02→ Common Stock (3,187 underlying) - Exercise/Conversion
Common Stock
2024-01-01+3,187→ 60,215 total
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Includes 360 and 307 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2023 and December 31, 2023, respectively.
- [F3]On March 3, 2021, the reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.